Inspiration Healthcare portfolio strengthens as it positions itself for long-term growth

Inspiration Healthcare is a global provider of medical technology for use in critical care & operating theatres. The company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

Med-tech group () hailed the successful integration of SLE, bought last year for GBP18mln, as it unveiled a strong set of interim results.

It said synergies and cross-selling opportunities were “being realised” and added: “The early successes reported in this interim report highlight a step towards realising the full advantages of the combined group and the innovative, diverse portfolio we can offer.”

Revenues for the six months ended July 31 were GBP20.9mln, up 47%, while underlying earnings (EBITDA) advanced 42% to GBP3.6mln.

Inspiration, which makes specialist kit used by neonatal intensive care and operating theatres, said its net cash position as at the period-end was GBP8.6mln.

() () said the financial year had started well, with the med-tech group trading in line with management expectations.

It said revenues for the six months to the end of July were 47% ahead of the same period last year as it benefited from an uplift from the SLE neonatal ventilator specialist it bought in 2020.

(), the neo-natal equipment specialist, said its good start to the year has continued.

“I can now confirm that the start to the financial year has been more than pleasing with interest in our products remaining high and that our order book remains strong,” Mark Abrahams, chairman, said in a trading statement ahead of the AGM.

In its chosen fields of perinatal and neonatal care, PLC () punches on a par with companies substantially larger including giant medical equipment manufacturers such as Philips and Siemens.

That’s pretty impressive given it only turned over GBP15mln to January 2019, but chief executive Neil Campbell says the company is widely recognised as a pioneer in the neonatal intensive sector.

Inspiration Healthcare PLC’s results today underline the progress it has made with both acquisitions and its neonatal strategy, said Cenkos.

Interim revenues rose by 47%, supported by the contribution of SLE, acquired in July 2020, while gross margin improved to 52.5% from 51.4% and underlying profits jumped by 42%.

“We believe these results clearly demonstrate the group-level benefits from both recent acquisitions (SLE and Viomedex) generating revenue synergies and margin improvements,” said Cenkos.

()’s () Neil Campbell talks to Proactive London about their revenues for the six months ended July 31 were GBP20.9mln, up 47%, while underlying earnings (EBITDA) advanced 42% to GBP3.6mln.

He highlights the successful integration of SLE, bought last year for GBP18mln and says their synergies and cross-selling opportunities reported in this interim report highlight a step towards realising the full advantages of the combined group and the innovative, diverse portfolio we can offer.

And he points to the strong order book which he says means they are now well-positioned to move into the next phase of the financial year.